Kisqali Femara Co-Pack — Cigna

Breast Cancer – Recurrent or Metastatic in Women

Initial criteria

Patient is age ≥ 18 years; AND
Patient has recurrent or metastatic disease; AND
Patient has hormone receptor-positive (HR+) [i.e., estrogen receptor-positive (ER+) and/or progesterone receptor-positive (PR+)] disease; AND
Patient has human epidermal growth factor receptor 2 (HER2)-negative breast cancer; AND
Patient meets ONE of the following (i or ii): i. Patient is postmenopausal OR ii. Patient is pre/perimenopausal and meets ONE of the following (a or b): a) Patient is receiving ovarian suppression/ablation with a gonadotropin-releasing hormone (GnRH) agonist OR b) Patient has had surgical bilateral oophorectomy or ovarian irradiation.

1 year